AbbVie Inc. (ABBV) financial statements and ratios from SEC XBRL: revenue $61.16B (TTM), net margin 6.9%, revenue growth 10.2% YoY, P/E 73.3. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $61.16B |
| Net Margin | 6.9% |
| Revenue Growth (YoY) | 10.2% |
| EPS Growth (YoY) | 292.3% |
| FCF Growth (YoY) | -36.2% |
| P/E Ratio | 73.3 |
| EV / EBITDA | 25.8 |
| Price / Sales | 7.19 |
| FCF Yield | 3.9% |
| DCF Value (model) | $91.17 |
| DCF Upside vs Price | -65.2% |
| Altman Z-Score | 2.56 (grey) |
| Piotroski F-Score | 6/9 |
| Sector P/E (Healthcare) | 21.6 |
ABBV overview · ABBV earnings · ABBV KPIs · ABBV investor relations · ABBV ownership · ABBV peers · ABBV filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.